用於治療涉及細胞增生，骨髓癌細胞之移動或凋零或血管生成之疾病之組合农业专利-农业学术服务平台

发明人:: STEFANIC, MARTIN FRIEDRICH,马汀　佛瑞德里奇　史帝芬尼克,馬汀　佛瑞德里奇　史帝芬尼克,HILBERG, FRANK,法兰克　希尔伯格,法蘭克　希爾伯格,MUNZERT, GERD,杰德　慕札特,傑德　慕札特,SOLCA, FLAVIO,富莱维尔　索卡,富萊維爾　索卡,BAUM, ANKE,安科　包姆,VAN MEEL, JACOBUS C.A.,贾可巴斯Ｃ　,马汀佛瑞德里奇史帝芬尼克,馬汀佛瑞德里奇史帝芬尼克,法兰克希尔伯格,法蘭克希爾伯格,杰德慕札特,傑德慕札特,富莱维尔索卡,富萊維爾索卡,安科包姆,贾可巴斯C

摘要：: The present invention relates to a pharmaceutical combination for the treatment of diseases which involves cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis. The invention also relates to a method for the treatment of said diseases, comprising co-administration of effective amounts of specific active compounds and/or co-treatment with radiation therapy, in a ratio which provides an additive and synergistic effect, and to the combined use of these specific compounds and/or radiotherapy for the manufacture of corresponding pharmaceutical combination preparations.本發明係關於治療涉及細胞增生、骨髓癌細胞之移動或凋零或血管生成之疾病之覽基組合。本發明亦關於治療該等疾病之方法，其包括共投予有效量之特定活性化合物，及/或以添加及協同作用的比例之放射治療共同治療，及這些特定化合物及/或放射治療用於製造同等的醫藥組合製備物之組合用途。